专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20090131412A1 NOVEL 2-QUINOLONE DERIVATIVE 审中-公开
标题翻译：新二氢喹诺酮衍生物
公开(公告)号：US20090131412A1
公开(公告)日：2009-05-21
申请号：US11916592
申请日：2006-06-05
申请人： Kazuhito Ikeda , Kazuo Kumagai , Katsunori Tsuboi , Nobuhisa Fukuda
发明人： Kazuhito Ikeda , Kazuo Kumagai , Katsunori Tsuboi , Nobuhisa Fukuda
IPC分类号： A61K31/4709 , A61K31/473 , A61K31/55 , A61K31/5377 , A61K31/4741 , C07D413/12 , C07D401/12 , C07D491/056
CPC分类号： C07D405/12 , C07D215/227 , C07D221/16 , C07D401/06 , C07D401/12 , C07D401/14 , C07D405/14 , C07D409/12 , C07D413/14 , C07D417/12 , C07D491/04
摘要： A compound represented by the formula (1) or a pharmaceutically acceptable salt thereof which has a therapeutic or prophylactic effect on an SNS-related disease such as neuropathic pain. (1) wherein R1 and R2 independently represent an alkyl group having 1 to 4 carbon atoms or the like, or R1 and R2 may together form a 5- to 7-membered ring; n represents a numerical number of 1 to 3; A represents a substituted or unsubstituted aryl group or the like or a formula: —N(R5)R6 (wherein R5 and R6 independently represent a substituted or unsubstituted alkyl group or the like); and R3 and R4 independently represent a substituted or unsubstituted alkyl group or the like, or R3 and R4 may together form a substituted or unsubstituted, saturated or unsubstituted nitrogenated heterocyclic ring, provided that both of R1 and R2 are not a hydrogen atom when R3 and R4 together form a piperidine ring.
摘要翻译：由式（1）表示的化合物或其药学上可接受的盐对SNS相关疾病如神经性疼痛具有治疗或预防作用。（1）其中R1和R2独立地表示具有1至4个碳原子的烷基等，或者R1和R2可以一起形成5-至7-元环; n表示1〜3的数字; A表示取代或未取代的芳基等或式：-N（R5）R6（其中R5和R6独立地表示取代或未取代的烷基等）; 并且R 3和R 4独立地表示取代或未取代的烷基等，或者R 3和R 4可以一起形成取代或未取代的饱和或未取代的氮杂环，条件是R 1和R 2不是氢原子， R4一起形成哌啶环。

2. 发明授权

US08258139B2 Method of treatment for mental disorders 有权
标题翻译：精神障碍治疗方法
公开(公告)号：US08258139B2
公开(公告)日：2012-09-04
申请号：US13113703
申请日：2011-05-23
申请人： Kazuhito Ikeda , Takeo Ishiyama
发明人： Kazuhito Ikeda , Takeo Ishiyama
IPC分类号： A61K31/497 , C07D241/04 , C07D403/00
CPC分类号： A61K31/496 , A61K9/0053 , A61K9/20 , A61K31/4035 , A61K31/428 , A61K45/06 , A61K2300/00
摘要： The invention relates to a medicament or a method for treating mental disorders, in detail, ADHD comprising lurasidone, or a combination of lurasidone and a D4 receptor agonist.
摘要翻译：本发明涉及治疗精神障碍的药物或方法，详细地，涉及包含卢卡西酮或杜拉司酮和D4受体激动剂的组合的ADHD。

3. 发明申请

US20060075972A1 Substrate processing apparatus and substrate processing method 审中-公开
公开(公告)号：US20060075972A1
公开(公告)日：2006-04-13
申请号：US11258670
申请日：2005-10-25
申请人： Seiyo Nakashima , Michiko Nishiwaki , Yukinori Aburatani , Satoshi Okada , Eisuke Nishitani , Kazuhiro Nakagomi , Kazuhito Ikeda , Kazuhiro Shimeno , Gakuji Ohta , Katsuhisa Kasanami
发明人： Seiyo Nakashima , Michiko Nishiwaki , Yukinori Aburatani , Satoshi Okada , Eisuke Nishitani , Kazuhiro Nakagomi , Kazuhito Ikeda , Kazuhiro Shimeno , Gakuji Ohta , Katsuhisa Kasanami
IPC分类号： C23C16/00
CPC分类号： H01L21/68721 , C23C16/4584 , C23C16/46 , H01J2237/2005 , H01J2237/32 , H01L21/67109 , H01L21/68742 , H01L21/68785 , H01L21/68792
摘要： A substrate processing apparatus comprises a processing chamber; a susceptor on which a substrate to be processed is to be placed; and a heating unit disposed below the susceptor for heating the substrate to be processed placed on the susceptor. The susceptor and the heating unit are accommodated in the processing chamber, and in a state in which the susceptor and the heating unit are relatively rotated, the substrate to be processed is processed. At least the susceptor is lifted and lowered in the processing chamber, and a substrate to be processed lifting and lowering apparatus for lifting and lowering the substrate to be processed with respect to at least a portion of the susceptor is disposed in the processing chamber.

4. 发明授权

US06190104B1 Treatment object conveyor apparatus, semiconductor manufacturing apparatus, and treatment object treatment method 有权
标题翻译：处理对象输送装置，半导体制造装置及处理对象处理方法
公开(公告)号：US06190104B1
公开(公告)日：2001-02-20
申请号：US09326673
申请日：1999-06-07
申请人： Kazuhito Ikeda , Shinichiro Watahiki , Hisashi Yoshida , Yukinori Aburatani
发明人： Kazuhito Ikeda , Shinichiro Watahiki , Hisashi Yoshida , Yukinori Aburatani
IPC分类号： B65G4907
CPC分类号： H01L21/67742 , H01L21/67757 , Y10S414/139
摘要： A method and apparatus for conveying a treatment object whereby a drive unit for driving a treatment object conveyor robot is deployed inside a vacuum chamber. The robot comprises a conveyor arm and a drive unit. The conveyor arm is accommodated outside an airtight vessel and the drive unit is accommodated inside the airtight vessel to avoid damage to the drive unit. In order to raise and lower the robot inside the chamber, an elevator mechanism, deployed outside the chamber, advances and retracts a shaft that is inserted in an airtight manner into the chamber. The airtight structure is secured by O rings provided where a bellows surrounds the shaft and connects to the chamber and the elevator mechanism. The shaft, inserted inside the chamber, is linked to the airtight vessel that accommodates the drive unit of the robot. The airtight vessel communicates to the outside via a hollow portion in the shaft and the interior thereof is always kept at atmospheric pressure.
摘要翻译：一种用于输送处理物体的方法和装置，由此用于驱动处理物体输送机器人的驱动单元部署在真空室内。机器人包括传送臂和驱动单元。输送臂被容纳在密封容器的外部，并且驱动单元容纳在密封容器的内部，以避免损坏驱动单元。为了升高和降低腔室内的机器人，布置在腔室外部的电梯机构使以气密方式插入腔室的轴前进和后退。气密结构由设置在波纹管围绕轴并连接到腔室和升降机构的O形环固定。插入室内的轴连接到容纳机器人的驱动单元的气密容器。气密容器通过轴中的中空部分与外部连通，其内部总是保持在大气压力。

5. 发明授权

US5632820A Thermal treatment furnace in a system for manufacturing semiconductors 失效
标题翻译：一种制造半导体系统的热处理炉
公开(公告)号：US5632820A
公开(公告)日：1997-05-27
申请号：US425924
申请日：1995-04-20
申请人： Tomoshi Taniyama , Hideki Kaihotsu , Yoshikatsu Kanamori , Kazuhito Ikeda , Shuji Yonemitsu
发明人： Tomoshi Taniyama , Hideki Kaihotsu , Yoshikatsu Kanamori , Kazuhito Ikeda , Shuji Yonemitsu
IPC分类号： C23C16/44 , C30B25/14 , H01L21/22 , H01L21/324 , C23C16/00
CPC分类号： C23C16/4409 , C23C16/4401 , C30B25/14
摘要： A thermal treatment furnace for use with a semiconductor system is provided. The thermal treatment furnace includes a scavenger which sealingly encloses a lower end of a reaction tube so as to diminish gas leakage from the reaction tube.
摘要翻译：提供了一种与半导体系统一起使用的热处理炉。热处理炉包括密封地包围反应管的下端的清除剂，以减少从反应管中的气体泄漏。

6. 发明授权

US06936736B2 Amide derivative 失效
标题翻译：酰胺衍生物
公开(公告)号：US06936736B2
公开(公告)日：2005-08-30
申请号：US10105271
申请日：2002-03-26
申请人： Kazuhito Ikeda , Tohru Tatsuno , Hiroki Ogo , Toshio Nishihara , Tatsuya Fujibayashi , Ryu Nagata
发明人： Kazuhito Ikeda , Tohru Tatsuno , Hiroki Ogo , Toshio Nishihara , Tatsuya Fujibayashi , Ryu Nagata
IPC分类号： C07C233/65 , C07C233/66 , C07C233/69 , C07C233/76 , C07C233/83 , C07C235/46 , C07C235/84 , C07C237/12 , C07C237/22 , C07C237/30 , C07C255/29 , C07D213/81 , C07D213/82 , C07D333/38 , C07C233/18 , A61K31/166 , A61P27/02 , A61P27/06 , C07C233/05
CPC分类号： C07D213/81 , C07C233/65 , C07C233/66 , C07C233/69 , C07C233/76 , C07C233/83 , C07C235/46 , C07C235/84 , C07C237/12 , C07C237/22 , C07C237/30 , C07C255/29 , C07D213/82 , C07D333/38
摘要： A compound of the formula: wherein Ar is optionally substituted phenyl, etc.; n is 0, 1 or 2; R1 is hydogen atom, optionally substituted alkyl, etc.; R2 and R3 are independently optionally substituted alkyl, etc.; R4 and R5 are independently hydrogen atom or optionally substituted alkyl; R6 is hydrogen atom, hydroxy or alkyl; or a pharmaceutically acceptable salt thereof is useful as a medicament for treating retinal degenerative disorders and the like.
摘要翻译：下式的化合物：其中Ar是任选取代的苯基等; n为0,1或2; R 1是氢原子，任选取代的烷基等; R 2和R 3独立地是任选取代的烷基等; R 4和R 5独立地是氢原子或任选取代的烷基; R 6是氢原子，羟基或烷基; 或其药学上可接受的盐可用作治疗视网膜退行性病症等的药物。

7. 发明授权

US09259423B2 Method of treatment for mental disorders 有权
标题翻译：精神障碍治疗方法
公开(公告)号：US09259423B2
公开(公告)日：2016-02-16
申请号：US13555044
申请日：2012-07-20
申请人： Kazuhito Ikeda , Takeo Ishiyama
发明人： Kazuhito Ikeda , Takeo Ishiyama
IPC分类号： A61K31/496 , A61K31/428 , A61K31/4035 , A61K45/06
CPC分类号： A61K31/496 , A61K9/0053 , A61K9/20 , A61K31/4035 , A61K31/428 , A61K45/06 , A61K2300/00
摘要： The invention relates to a medicament or a method for treating mental disorders, in detail, ADHD comprising lurasidone, or a combination of lurasidone and a D4 receptor agonist.
摘要翻译：本发明涉及治疗精神障碍的药物或方法，详细地，涉及包含卢卡西酮或杜拉司酮和D4受体激动剂的组合的ADHD。

8. 发明授权

US06384033B1 Amide derivative 失效
标题翻译：酰胺衍生物
公开(公告)号：US06384033B1
公开(公告)日：2002-05-07
申请号：US09559626
申请日：2000-04-27
申请人： Kazuhito Ikeda , Tohru Tatsuno , Hiroki Ogo , Toshio Nishihara , Tatsuya Fujibayashi , Ryu Nagata
发明人： Kazuhito Ikeda , Tohru Tatsuno , Hiroki Ogo , Toshio Nishihara , Tatsuya Fujibayashi , Ryu Nagata
IPC分类号： A61K314402
CPC分类号： C07D213/81 , C07C233/65 , C07C233/66 , C07C233/69 , C07C233/76 , C07C233/83 , C07C235/46 , C07C235/84 , C07C237/12 , C07C237/22 , C07C237/30 , C07C255/29 , C07D213/82 , C07D333/38
摘要： A compound of the formula: wherein Ar is optionally substituted phenyl, etc.; n is 0, 1 or 2; R1 is hydogen atom, optionally substituted alkyl, etc.; R2 and R3 are independently optionally substituted alkyl, etc.; R4 and R5 are independently hydrogen atom or optionally substituted alkyl; R6 is hydrogen atom, hydroxy or alkyl; or a pharmaceutically acceptable salt thereof is useful as a medicament for treating retinal degenerative disorders and the like.
摘要翻译：下式的化合物：其中Ar是任选取代的苯基等; n为0,1或2; R1为氢原子，任选取代的烷基等; R2和R3独立地是任选取代的烷基等; R 4和R 5独立地是氢原子或任选取代的烷基; R6是氢原子，羟基或烷基;或其药学上可接受的盐可用作治疗视网膜退行性病症等的药物。

9. 发明授权

US06194461B1 Nitrone derivatives 失效
标题翻译：硝基衍生物
公开(公告)号：US06194461B1
公开(公告)日：2001-02-27
申请号：US09254856
申请日：1999-03-15
申请人： Kazuhito Ikeda , Tohru Tatsuno , Hiroki Ogo , Shuji Masumoto , Tatsuya Fujibayashi , Ryu Nagata
发明人： Kazuhito Ikeda , Tohru Tatsuno , Hiroki Ogo , Shuji Masumoto , Tatsuya Fujibayashi , Ryu Nagata
IPC分类号： A61K3115
CPC分类号： C07C291/02 , A61K31/137 , A61K31/15 , A61K31/357 , A61K31/381 , A61K31/40 , A61K31/415 , A61K31/4164 , A61K31/4402 , C07C215/08 , C07C217/08 , C07C219/06
摘要： A compound represented by the figure (1) or a pharmaceutically acceptable salt thereof is useful as medicament for treating retinal degenerative disorders: wherein Ar is optionally substitued phenyl or optionally substituted heteroaryl;. n is 0, 1 or 2; W is —CH2NH— or —CH═N(O)—; R1, R2 and R3 are independently optionally substituted alkyl, carboxyl or alkoxycarbonyl; any two groups of R1, R2 and R3 may be taken together with the carbon atom to form optionally substituted cycloalkane; all of R1, R2 and R3 may be taken together with the adjusent carbon atom to form optionally substituted bicycloalkane or optionally substituted tricycloalkane; R4 and R5 are independently hydrogen atom or optionally substituted alkyl.
摘要翻译：由图（1）表示的化合物或其药学上可接受的盐可用作治疗视网膜退行性疾病的药物：其中Ar任选被取代的苯基或任选取代的杂芳基; n是0,1或2; W是-CH 2 NH- 或-CH = N（O） - ; R 1，R 2和R 3独立地是任选取代的烷基，羧基或烷氧基羰基; R 1，R 2和R 3的任何两个基团可以与碳原子一起形成任选取代的环烷烃; R 1，R 2和R 3可以与下述碳原子一起形成任选取代的双环烷烃或任选取代的三环烷烃; R 4和R 5独立地为氢原子或任选取代的烷基。

10. 发明申请

US20070105948A1 Therapeutic or preventive agents for ischemic neuropathy 审中-公开
标题翻译：缺血性神经病的治疗或预防剂
公开(公告)号：US20070105948A1
公开(公告)日：2007-05-10
申请号：US10581663
申请日：2004-11-30
申请人： Kazuhito Ikeda , Toru Kimura
发明人： Kazuhito Ikeda , Toru Kimura
IPC分类号： A61K31/353
CPC分类号： C07D311/86 , A61K31/352 , A61K31/353
摘要： Therapeutic or preventive agents for ischemic nerve injury containing as the active ingredient compounds represented by the general formula [2]: wherein R1 and R4 are each independently hydrogen, carboxy, or alkoxycarbonyl; and R2 and R5 are each independently hydrogen, hydroxy group, or acyloxy group.
摘要翻译：含有由通式[2]表示的活性成分化合物的缺血性神经损伤的治疗或预防剂：其中R 1和R 4各自独立地为氢，羧基，或烷氧基羰基; R 2和R 5各自独立地为氢，羟基或酰氧基。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式